4-[4-(1,1-Dimethylethyl)phenyl]-1H-pyrazole, 500mg

3'-Amino-biphenyl-4-carbonitrile, 95.0%, 1g

Ethyl 3-oxo-3-(3-pyridyl)propionate, 95.0%, 25g

3-(Piperazin-1-yl)propionic acid ethyl ester, 98.0%, 1g

Pipetta multicanale per microlitri Pipetman® G a 8 canali, da 20 a 200 µl, P8x200G, 1 pezzo

2-Amino-5-(trifluoromethyl)-1,3,4-thiadiazole, 97.0%, 10g

5,5-Dimethyl-2-(p-tolyl)-1,3,2-dioxaborinane, 98.0%, 5g

1-Bromo-4-(3,3,3-trifluoropropyl)benzene, 95.0%, 250mg

4-Fluoro-3-methylbenzoic acid, 97.0%, 1g

((2R,3R,5R)-3-(benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate, 97%, 1g

(S)-3-Aminotetrahydrothiophene 1,1-dioxide hydrochloride, 98%, 1g

2,5-Dibromothieno[3,2-b]thiophene, 95.0%, 10g

Grandi incubatori Heratherm General Protocol, 405 l, IGS400, 1 pezzo